Market Overview

UPDATE: ISI Group Initiates CVS Caremark at Overweight, $53.50 PT

Share:
Related CVS
Morgan Stanley Downgrades CVS Health Amid An 'Increasingly Competitive' PBM Market
The Market In 5 Minutes: Believeland
What The Planned Supermarket Merger Means For Union Bankhares (Seeking Alpha)

ISI Group initiated its coverage on CVS Caremark (NYSE: CVS) with a rating of Overweight and a price target of $53.50.

ISI Group commented, "Our thesis for CVS is based on our view of continued share gain at the pharmacy given the success of Maintenance Choice and the continuation of the WAG/ESRX dispute, improved growth and profitability at Caremark as a result of innovative solutions and the streamlining initiative, and a very shareholder friendly approach to capital deployment and enhanced capital returns."

CVS Caremark closed at $46.90 on Wednesday.

Latest Ratings for CVS

DateFirmActionFromTo
Jun 2016Morgan StanleyDowngradesEqual-weight
May 2016JefferiesMaintainsBuy
May 2016CitigroupMaintainsNeutral

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

Posted-In: ISI GroupAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (CVS)

View Comments and Join the Discussion!